A detailed history of Proficio Capital Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Proficio Capital Partners LLC holds 4,031 shares of BMY stock, worth $163,053. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,031
Holding current value
$163,053
% of portfolio
0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $193,407 - $219,286
4,031 New
4,031 $218,000
Q3 2023

Oct 18, 2023

SELL
$57.89 - $64.73 $21,998 - $24,597
-380 Reduced 2.18%
17,023 $988,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $61,862 - $68,688
-971 Reduced 5.28%
17,403 $1.11 Million
Q1 2023

Apr 21, 2023

SELL
$65.71 - $74.53 $82.6 Million - $93.7 Million
-1,257,558 Reduced 98.56%
18,374 $1.27 Million
Q1 2023

Apr 19, 2023

BUY
$65.71 - $74.53 $82.6 Million - $93.7 Million
1,256,542 Added 6480.36%
1,275,932 $88.4 Million
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $1.06 Million - $1.25 Million
15,446 Added 391.63%
19,390 $1.39 Million
Q3 2022

Oct 11, 2022

BUY
$0.13 - $76.84 $2 - $1,613
21 Added 0.54%
3,944 $287,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $363 - $399
5 Added 0.13%
3,923 $302,000
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $82,075 - $98,416
-1,335 Reduced 25.41%
3,918 $286,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $35,985 - $41,950
-671 Reduced 11.33%
5,253 $328,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $4,733 - $5,544
-80 Reduced 1.33%
5,924 $351,000
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $61,105 - $66,543
987 Added 19.67%
6,004 $401,000
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $44,326 - $49,854
-747 Reduced 12.96%
5,017 $317,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $37,761 - $42,791
654 Added 12.8%
5,764 $358,000
Q3 2020

Nov 02, 2020

SELL
$57.43 - $63.64 $19,813 - $21,955
-345 Reduced 6.32%
5,110 $308,000
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $28,561 - $33,390
-521 Reduced 8.72%
5,455 $321,000
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $86,257 - $125,352
1,859 Added 45.15%
5,976 $310,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $202,597 - $264,270
4,117 New
4,117 $264,000
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $148,711 - $176,318
-3,477 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $65,680 - $72,628
1,472 Added 73.42%
3,477 $158,000
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $19,627 - $23,403
435 Added 27.71%
2,005 $96,000
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $3,071 - $3,983
63 Added 4.18%
1,570 $82,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $1,379 - $1,556
-25 Reduced 1.63%
1,507 $94,000
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $36,886 - $45,975
-730 Reduced 32.27%
1,532 $85,000
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $2,396 - $2,759
-40 Reduced 1.74%
2,262 $143,000
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $5,394 - $5,881
90 Added 4.07%
2,302 $141,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $122,168 - $140,992
2,212
2,212 $141,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.